-
GenOptima Launches Results-as-a-Service GEO Infrastructure to Help Enterprises Ensure Outcome in AI Search
SHANGHAI, July 16, 2026 (GLOBE NEWSWIRE) — GenOptima, an enterprise Generative Engine Optimization (GEO) infrastructure provider, announced the launch of its Results-as-a-Service (RaaS)-based GEO solution, designed to help organizations ensure outcome through measurable AI search visibility management as AI-powered search platforms continue to reshape how brands are discovered, interpreted, and recommended. GenOptima — Brand Consensus…
-
Lumina Datamatics Recognized as One of the Most Preferred Workplaces 2026-27 for the 2nd Consecutive Year by Marksmen Daily
MUMBAI, India, July 13, 2026 /PRNewswire/ — Lumina Datamatics, a strategic partner to global publishers and eCommerce retailers, has been recognized as one of the Most Preferred Workplaces 2026–27 by Marksmen Daily for the second consecutive year. The recognition was presented at the 6th Edition of the Most Preferred Workplace Awards, held in association with…
-
Frost & Sullivan Institute Honors Organizations Driving Transformative Impact Through Visionary Leadership
SILICON VALLEY, Calif., June 26, 2026 /PRNewswire/ — The Frost & Sullivan Institute is proud to announce the recipients of the 2026 Visionary Growth Leadership Best Practices Recognition, honoring organizations that are setting new benchmarks for business leadership by tackling some of the world’s most critical challenges. This recognition celebrates enterprises that have successfully aligned…
-
Frost & Sullivan Identifies Virtual Healthcare Assistants as a Transformational Force in Healthcare Delivery
New analysis highlights significant growth opportunities in patient- and clinician-facing AI assistants as healthcare organizations seek to improve efficiency, patient engagement, and care outcomes LONDON, June 18, 2026 /PRNewswire/ — Frost & Sullivan’s latest analysis, Innovations and Growth Opportunities in Virtual Healthcare Assistants, finds that artificial intelligence-powered virtual healthcare assistants are poised to transform healthcare delivery…
-
Frost & Sullivan Institute Celebrates Visionary Companies Addressing the World’s Most Pressing Challenges
SILICON VALLEY, Calif., June 15, 2026 /PRNewswire/ — The Frost & Sullivan Institute is pleased to present the 2026 Visionary Growth Leadership Best Practices Recognition, celebrating leading enterprises that are redefining the role of business in addressing the world’s most urgent challenges. This recognition honors organizations that have embedded innovation, measurable impact, and long-term sustainability…
-
UCB Transforms Safety Operations with Veeva Safety Suite in Collaboration with ELIQUENT Life Sciences, Pinnaxis, and Daelight Solutions
WASHINGTON, June 12, 2026 /PRNewswire/ — ELIQUENT Life Sciences (“ELIQUENT”) today announced the June 1 go-live of Veeva Safety Suite at UCB. As one of the first organizations to adopt the complete suite, UCB is unifying its global safety operations in a transformation delivered through a strategic collaboration between Veeva, ELIQUENT, Pinnaxis, and Daelight Solutions.…
-
Cloudeva.ai Debuts as a Cloud Decision Intelligence Offering Public Preview Now Open
Bengaluru, Karnataka, India Cloudeva.ai, a cloud intelligence platform that differentiates itself through multi-cloud capabilities & an intelligent advisory bot, officially launches today, with a premise that organizations don’t have a cloud technology problem, they have a cloud decision problem. Amit Gupta, Founder Rapyder and Cloudeva.ai Built by teams with years of hands-on experience supporting cloud…
-
Akums Reports Q2 FY26 Results; Strengthens International Presence
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the second quarter of FY26. The CDMO segment remained the key contributor with revenue of Rs. 804 crore. Volumes for the CDMO vertical grew 7% y-o-y, as against muted industry volume growth, reflecting…
-
Akums Delivers Strong Q3 FY26 Performance with 14.8% Revenue Growth and 21% Adj EBITDA Growth
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the third quarter of FY26. Q3 FY 26 saw strong performance across its key business segments. CDMO saw a revenue growth of over 16% spurred on by double digit increase in volumes. The…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
